1. Home
  2. FSS vs IBRX Comparison

FSS vs IBRX Comparison

Compare FSS & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Federal Signal Corporation

FSS

Federal Signal Corporation

N/A

Current Price

$128.29

Market Cap

7.8B

ML Signal

N/A

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

N/A

Current Price

$7.59

Market Cap

7.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FSS
IBRX
Founded
1901
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.8B
7.5B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
FSS
IBRX
Price
$128.29
$7.59
Analyst Decision
Buy
Strong Buy
Analyst Count
4
7
Target Price
$131.75
$12.57
AVG Volume (30 Days)
438.3K
9.0M
Earning Date
04-29-2026
05-08-2026
Dividend Yield
0.46%
N/A
EPS Growth
14.57
38.71
EPS
2.54
N/A
Revenue
$2,180,500,000.00
$113,288,000.00
Revenue This Year
$20.94
$88.59
Revenue Next Year
$6.79
$131.15
P/E Ratio
$49.80
N/A
Revenue Growth
17.14
668.31
52 Week Low
$101.19
$1.95
52 Week High
$134.51
$12.43

Technical Indicators

Market Signals
Indicator
FSS
IBRX
Relative Strength Index (RSI) 59.20 51.28
Support Level $106.17 $6.68
Resistance Level $132.26 $8.46
Average True Range (ATR) 4.32 0.38
MACD 0.75 0.05
Stochastic Oscillator 78.48 89.05

Price Performance

Historical Comparison
FSS
IBRX

About FSS Federal Signal Corporation

Federal Signal Corp designs and manufactures products and integrated solutions for municipal, governmental, industrial, and airport customers. It operates through two segments. The Environmental Solutions Group manufactures and supplies street sweeper vehicles, sewer cleaner and vacuum loader trucks, hydro-excavation trucks, high-performance water blasting equipment, dump truck bodies, and trailers. The Safety and Security Systems Group manufactures and supplies comprehensive systems and products used by law enforcement, fire rescue, and industrial sites to protect people and property. Its offerings include systems for community alerting and industrial communications. The company generates the majority of its revenue from the Environmental Solutions Group segment.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

Share on Social Networks: